Nasomet (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasomet, is a glucocorticoid presented as a nasal spray for topical nasal use. It is indicated for the management of allergic rhinitis, seasonal and perennial forms, and for reducing nasal polyps in appropriate patients.

GNH USA supplies Nasomet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Clients benefit from consistent batch release, comprehensive documentation, and responsive technical support throughout the procurement process.

Nasomet, a nasal corticosteroid, acts on inflammatory pathways of the nasal mucosa to relieve allergy‑related symptoms.

Allergic rhinitis: reduces nasal congestion, itching and sneezing by decreasing mucosal inflammation. Seasonal allergic rhinitis: provides symptom relief during pollen seasons through local anti‑inflammatory action. Perennial allergic rhinitis: controls year‑round nasal inflammation and improves airflow. Nasal polyps: helps shrink polyps and improves nasal patency in affected individuals.

Nasomet may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Throat irritation or dryness - Cough - Altered taste or bitter taste

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Cataract formation or glaucoma - Fungal infection of the nasal mucosa - Severe allergic reaction including anaphylaxis - Nasal septum perforation - Vision changes or ocular pressure increase

Before prescribing Nasomet, consider the following precautions to ensure safe and effective use.

Assess for active nasal or sinus infection: avoid use until infection resolved. Monitor intra‑ocular pressure in patients with glaucoma or cataract risk. Evaluate for adrenal insufficiency in patients on systemic steroids. Limit duration of continuous therapy: use the lowest effective dose for the shortest period. Use with caution in children: pediatric dosing should be determined by a physician. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasomet can interact with other medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure. - Concurrent systemic corticosteroids: heightened risk of systemic glucocorticoid effects. - Live vaccines: nasal steroid may diminish local immune response.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): may modestly raise mometasone levels. - Ritonavir or other protease inhibitors: potential increase in exposure. - Nasal decongestants (e.g., oxymetazoline): may increase local irritation.